Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Sodium Nitrite in HFpEF
NCT02262078Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Oct 2014
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of inhaled nitrite in heart failure with preserved ejection fraction (HFpEF) (2 arms), sponsored by Mayo Clinic. Primary endpoint: Change in Pulmonary Capillary Wedge Pressure During Exercise. Started Oct 2014; status: completed.
02
Drugs
inhaled nitrite
03
Conditions
heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on NCT02262078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02262078.